The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) closed the day trading at $0.54 up 0.98% from the previous closing price of $0.53. In other words, the price has increased by $0.98 from its previous closing price. On the day, 3.92 million shares were traded.
Ratios:
For a better understanding of LXRX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.22 and its Current Ratio is at 2.22. In the meantime, Its Debt-to-Equity ratio is 0.86 whereas as Long-Term Debt/Eq ratio is at 0.51.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on March 05, 2025, Downgraded its rating to Market Perform and sets its target price to $1 from $2 previously.
On June 17, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.
On April 30, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $5.Leerink Partners initiated its Outperform rating on April 30, 2024, with a $5 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 15 ’24 when COATS LONNEL bought 300,000 shares for $1.60 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 6.23 while its Price-to-Book (P/B) ratio in mrq is 1.58.
Stock Price History:
Over the past 52 weeks, LXRX has reached a high of $2.45, while it has fallen to a 52-week low of $0.28. The 50-Day Moving Average of the stock is 2.97%, while the 200-Day Moving Average is calculated to be -48.52%.
Shares Statistics:
A total of 363.18M shares are outstanding, with a floating share count of 177.07M. Insiders hold about 51.24% of the company’s shares, while institutions hold 26.48% stake in the company.
